CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP, Regulatory Affairs and QA acquired 34,050 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 52,200 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 26,253 shares at $15.93 ($418,210)
- 4 Option exercise President and CEO acquired 33,000 shares (option exercise)
- 4 Option exercise COO, CFO acquired 4,000 shares (option exercise)
- 4 Open-market sale 10% owner sold 474,500 shares at an average $21.63 ($10,264,415)
- 4 Option exercise President and CEO acquired 20,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift COO, CFO gave 2,725 shares (gift)
- 4 Derivatives Options or other derivatives
Page 4 of 10 · 190 filings